Contact us
Please fill out the details below and we will get back to you shortly.
Thank you!
We will be contacting you soon..
Close
We will be contacting you soon..
Oops! Something went wrong while submitting the form.
October 2024 - At the Partnership Opportunities in Drug Delivery (PODD) conference, Robert Hidalgo showcased Portal Instrument's latest advancements on its reusable, electro-mechanical drug delivery platform.
Boston, MA – October 27, 2024– Portal Instruments, a leader in innovative drug delivery technology, presented its latest advancements in its drug delivery injection systems at the Partnership Opportunities in Drug Delivery (PODD) conference. Robert Hidalgo, VP of Operations, delivered a presentation highlighting the transformative potential of the company’s technology to revolutionize the patient experience.
PODD, a premier event for the pharmaceutical and drug delivery industries, provided an ideal platform for Portal Instruments to showcase its cutting-edge technology to key stakeholders and potential partners. Hidalgo’s presentation emphasized the significant challenges associated with traditional needle-based injections, including viscosity challenges, patient anxiety and environmental waste. Portal’s platform offers a compelling solution, aiming to eliminate these issues and significantly enhance the patient experience.
"Our electro-mechanical platform is designed to address the significant unmet needs in injectable drug delivery and solve the challenges of delivering high viscosity drugs while also taking care of the patient and the planet," said Robert Hidalgo
The PODD conference offered a valuable opportunity for Portal Instruments to connect with potential partners in the pharmaceutical and biotech sectors.
March 23, 2021 - Cambridge, MA The Sumaira Foundation for NMO (TSF) and Portal Instruments are pleased to announce their partnership. Portal Instruments and TSF share a joint vision of creating a better experience and improved treatment options for patients diagnosed with NMOSD.
November 21, 2023 - Patrick Anquetil, CEO of Portal Instruments, takes the stage at LSI's 2023 Emerging MedTech Summit in Dana Point, California. Tune in to the recorded session to hear Dr. Anquetil dive into the innovative world of of needle-free and Portal's groundbreaking needle-free technology.
October 2019 - Drug development is a costly, long, and uncertain endeavor. The cost of taking a drug from preclinical research through market approval is $2.6 billion according to a recent study by the Tufts Center for the Study of Drug Development.
Please fill out the details below and we will get back to you shortly.